Telix Pharmaceuticals Ltd reported 13.48M in Gross Profit on Sales for its first fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Cochlear COH:AU $ 632.6M 14.8M
CSL CSL:AU $ 3.31B 1.44B
Integral Diagnostics Ltd IDX:AU 169.48M 2.76M
Mayne Pharma MYX:AU $ 94.83M 1.79M
Paradigm Biopharmaceuticals Ltd PAR:AU 7.74M 7.06M
Polynovo Ltd PNV:AU 22.01M 4.78M
Ramsay Health Care RHC:AU $ 4.91B 229.8M
ResMed RMD:AU $ 757.15M 265.95M
Sonic Healthcare SHL:AU $ 3.79B 155.43M